Companies Cryptocurrencies
Cumberland Pharmaceuticals Inc
Cumberland Pharmaceuticals Inc
Exchange: Nasdaq Global Select
IPO Date: 11/08/2009
CEO: Mr. A. Kazimi
Drug Manufacturers General Specialty & Generic Healthcare 🔗
  • CPIX
  • 2.19
  • 32109562
    market cap
  • -0.15999985
If you bought

shares of Cumberland Pharmaceuticals Inc (CPIX) on
You would have made
Old Price $12 Current Price $12

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. The company is headquartered in Nashville, Tennessee and currently employs 80 full-time employees. The firm is focused on the acquisition, development and commercialization of branded prescription products. The firm operates through specialty pharmaceutical products segment. The firm’s product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Vaprisol (conivaptan) Injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Hepatoren (ifetroban) Injection, and Boxaban (ifetroban) oral capsules for the treatment of patients with aspirin-exacerbated respiratory disease (AERD).

Address: 2525 W End Ave Ste 950 Nashville TENNESSEE 37203

Stay updated.